Verifying…
Home / Drug A–Z / Ragezugi Tablets

Ragezugi Tablets

NAFDAC Reg. No. B4-6395 · Drug

Registered with NAFDAC. Registration activeAs of 27 October 2026 · synced automatically from official sources.
Product
Ragezugi Tablets
NAFDAC number
B4-6395
Active ingredient
Diclofenac Potassium; Paracetamol
Strength
50 mg; 500 mg
Form
Tablet
Pack size
10 x 10's (in blisters)
Manufacturer
Not listed
Applicant (holder)
Freshborn Industries Ltd
Approved
28 Oct 2021
Status
Active View on NAFDAC ↗
Registration valid to
27 Oct 2026
WHO alerts
None found
Community reports
None
Times checked
0

What we found

  • Ragezugi Tablets is on the NAFDAC register with an active registration (B4-6395). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

What Ragezugi Tablets is used for

From the official U.S. FDA label for diclofenac potassium, the active ingredient registered with NAFDAC.

What it is used for

(s)  for the temporary relief of arthritis pain ONLY in the following areas  head, wrist, elbow (upper body areas)  foot, ankle, knee (lower body areas)  this product may take up to 7 days to work for arthritis pain; it is not for immediate relief. If no pain relief in 7 days, stop use.

Purpose

Arthritis pain reliever

Possible side effects

 pain gets worse or lasts more than 21 days  redness or swelling is present in the painful area  fever occurs  skin irritation occurs  any new symptoms appear. These could be signs of a serious condition.  you experience any of the following signs of stomach bleeding:  feel faint  have bloody or black stools  vomit blood  have stomach pain that does not get better  you have symptoms of heart problems or stroke:  chest pain  trouble breathing  leg swelling  weakness in one part of side of body  slurred speech

Do not use if

 if you have ever had an allergic reaction to any other pain reliever or to a fever reducer  for strains, sprains, bruises or sports injuries. This product has not been shown to work for these types of injuries.  right before or after heart surgery  on more than 2 body areas at the same time  in the eyes, nose or mouth

Warnings

For external use only Allergy alert: Diclofenac may cause a severe allergic reacction, expecially in people allergic to aspirin. Symptoms may include:  hives  asthma (wheezing)  skin reddening  blisters  facial swelling  shock  rash If an allergic reaction occurs, stop use and seek medical help right away. Liver warning: This product contains diclofenac. Liver damage may occur if you apply:  more or for a longer time than directed  when using other drugs containing diclofenac Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. …

Pregnancy & breastfeeding

Pregnancy/Breastfeeding If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use diclofenac at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

Storage

Storage  store at 20˚ to 25˚C (68˚ to 77˚F). Keep from freezing.

General information only, not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

Check your pack of Ragezugi Tablets

Add the expiry date on your pack for a full Trust Score.

3 free checks left today Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About Ragezugi Tablets

What is in Ragezugi Tablets?

Ragezugi Tablets contains Diclofenac Potassium; Paracetamol (50 mg; 500 mg), as tablet, according to its NAFDAC registration record.

Is Ragezugi Tablets registered with NAFDAC?

Yes. Ragezugi Tablets is listed on the NAFDAC register under registration number B4-6395, and its registration is active as of 27 October 2026.

Has Ragezugi Tablets been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Ragezugi Tablets in our automatically synced alert list.

How can I check that my pack of Ragezugi Tablets is genuine?

Run a free authenticity scan with the NAFDAC number B4-6395, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is Ragezugi Tablets used for?

(s)  for the temporary relief of arthritis pain ONLY in the following areas  head, wrist, elbow (upper body areas)  foot, ankle, knee (lower body areas)  this product may take up to 7 days to work for arthritis pain; it is not for immediate relief. If no pain relief in 7 days, stop use. (Summarised from the official U.S. FDA label for diclofenac potassium. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Ragezugi Tablets? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.